Correlation Between AnaptysBio and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Terns Pharmaceuticals, you can compare the effects of market volatilities on AnaptysBio and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Terns Pharmaceuticals.
Diversification Opportunities for AnaptysBio and Terns Pharmaceuticals
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between AnaptysBio and Terns is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of AnaptysBio i.e., AnaptysBio and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between AnaptysBio and Terns Pharmaceuticals
Given the investment horizon of 90 days AnaptysBio is expected to under-perform the Terns Pharmaceuticals. In addition to that, AnaptysBio is 2.13 times more volatile than Terns Pharmaceuticals. It trades about -0.18 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.18 per unit of volatility. If you would invest 675.00 in Terns Pharmaceuticals on August 25, 2024 and sell it today you would lose (96.00) from holding Terns Pharmaceuticals or give up 14.22% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
AnaptysBio vs. Terns Pharmaceuticals
Performance |
Timeline |
AnaptysBio |
Terns Pharmaceuticals |
AnaptysBio and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AnaptysBio and Terns Pharmaceuticals
The main advantage of trading using opposite AnaptysBio and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Akari Therapeutics PLC | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |